Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort studyMichela Botta, Liselotte Hol, Dave A. Dongelmans et al.|The Lancet Respiratory Medicine|2020Cited by 306
Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trialLore Vanderbeke, Nico Janssen, Dennis C. J. J. Bergmans et al.|Intensive Care Medicine|2021Cited by 98
RELAx – REstricted versus Liberal positive end-expiratory pressure in patients without ARDS: protocol for a randomized controlled trialFrederique Paulus, Anna Geke Algera, Luigi Pisani et al.|Trials|2018Cited by 22
Mortality associated with early changes in ARDS severity in COVID–19 patients – Insights from the PRoVENT–COVID studyM.T.U. Schuijt, Eline Kho, Ignacio Martín‐Loeches et al.|Journal of Critical Care|2021Cited by 12